T1	Participants 102 139	patients with advanced solid tumours:
T2	Participants 503 539	Patients with advanced solid tumours
T3	Participants 852 887	Twenty-seven patients were treated;
T4	Participants 1237 1246	detected.
T5	Participants 1247 1287	Four patients achieved partial responses
